Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population
<h3>Purpose</h3><p dir="ltr">To identify the impact of <i>CYP2C9*2, *3, VKORC1−1639 G>A </i>and <i>CYP4F2*3</i> on warfarin dose in an Arab population. To compare the accuracy of a clinical warfarin dosing (CWD) versus genetic warfarin dosing al...
محفوظ في:
| المؤلف الرئيسي: | Amr M. Fahmi (21632909) (author) |
|---|---|
| مؤلفون آخرون: | Ahmed El Bardissy (22155949) (author), Mohamed Omar Saad (12535545) (author), Amr Fares (22155952) (author), Ahmed Sadek (4588474) (author), Mohamed Nabil Elshafei (9960500) (author), Asma Eltahir (14158923) (author), Asmaa Mohamed (19870274) (author), Hazem Elewa (3592601) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)
حسب: Amr M. Fahmi (21632909)
منشور في: (2024) -
Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
حسب: Muhammad Salem (8979428)
منشور في: (2021) -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
حسب: Islam, Eljilany
منشور في: (2022) -
Effect of SAMe-TT<sub>2</sub>R<sub>2</sub> score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
حسب: Hazem Elewa (3592601)
منشور في: (2020) -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
حسب: Islam Eljilany (14151588)
منشور في: (2023)